In liver, TLR4 is expressed by all parenchymal and non-parenchymal cell types, and contributes to tissue damage, liver fibrosis, NASH, and HCC progression (reviewed in [20–24]). The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatohepatitis.